Selim Omar A, Lakhani Saad, Midha Swati, Mosahebi Afshin, Kalaskar Deepak M
Department of Surgical Biotechnology, Division of Surgery and Interventional Sciences, Royal Free Hospital, University College London (UCL), London, United Kingdom.
Department of Surgical Biotechnology, Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi, India.
Tissue Eng Part B Rev. 2022 Apr;28(2):295-335. doi: 10.1089/ten.TEB.2020.0355. Epub 2021 Apr 9.
Reconstruction of peripheral nerve injuries (PNIs) with substance loss remains challenging because of limited treatment solutions and unsatisfactory patient outcomes. Currently, nerve autografting is the first-line management choice for bridging critical-sized nerve defects. The procedure, however, is often complicated by donor site morbidity and paucity of nerve tissue, raising a quest for better alternatives. The application of other treatment surrogates, such as nerve guides, remains questionable, and it is inefficient in irreducible nerve gaps. More importantly, these strategies lack customization for personalized patient therapy, which is a significant drawback of these nerve repair options. This negatively impacts the fascicle-to-fascicle regeneration process, critical to restoring the physiological axonal pathway of the disrupted nerve. Recently, the use of additive manufacturing (AM) technologies has offered major advancements to the bioengineering solutions for PNI therapy. These techniques aim at reinstating the native nerve fascicle pathway using biomimetic approaches, thereby augmenting end-organ innervation. AM-based approaches, such as three-dimensional (3D) bioprinting, are capable of biofabricating 3D-engineered nerve graft scaffolds in a patient-specific manner with high precision. Moreover, realistic models of peripheral nerve tissues that represent the physiologically and functionally relevant environment of human organs could also be developed. However, the technology is still nascent and faces major translational hurdles. In this review, we spotlighted the clinical burden of PNIs and most up-to-date treatment to address nerve gaps. Next, a summarized illustration of the nerve ultrastructure that guides research solutions is discussed. This is followed by a contrast of the existing bioengineering strategies used to repair peripheral nerve discontinuities. In addition, we elaborated on the most recent advances in 3D printing and biofabrication applications in peripheral nerve modeling and engineering. Finally, the major challenges that limit the evolution of the field along with their possible solutions are also critically analyzed. Impact statement Complex nerve injuries, including critical-sized gaps (>3 cm loss of substance), gaps involving nerve bifurcations, and those associated with ischemic environments, are difficult to manage. A biomimetic, personalized peripheral nerve tissue surrogate to address these injuries is lacking. The peripheral nerve repair market currently represents a multi-billion-dollar industry that is projected to expand. Given the clinical and economical dilemmas posed by this medical condition, it is crucial to devise novel and effective nerve substitutes. In this review article, we discuss progress in three-dimensional printing technologies, including biofabrication and nerve computer-aided design modeling, toward achieving a patient-specific and biomimetic nerve repair solution.
由于治疗方案有限且患者预后不尽人意,修复伴有组织缺损的周围神经损伤(PNIs)仍然具有挑战性。目前,自体神经移植是桥接临界尺寸神经缺损的一线治疗选择。然而,该手术常常因供体部位并发症和神经组织匮乏而变得复杂,这引发了人们对更好替代方案的探索。其他治疗替代方法,如神经导管的应用,仍然存在疑问,并且在不可缩小的神经间隙中效果不佳。更重要的是,这些策略缺乏针对个性化患者治疗的定制化,这是这些神经修复方案的一个重大缺陷。这对束间再生过程产生负面影响,而束间再生过程对于恢复受损神经的生理轴突通路至关重要。最近,增材制造(AM)技术为PNI治疗的生物工程解决方案带来了重大进展。这些技术旨在使用仿生方法恢复天然神经束通路,从而增强终末器官的神经支配。基于AM的方法,如三维(3D)生物打印,能够以患者特异性的方式高精度地生物制造3D工程化神经移植物支架。此外,还可以开发代表人体器官生理和功能相关环境的逼真的周围神经组织模型。然而,该技术仍处于起步阶段,面临着重大的转化障碍。在这篇综述中,我们重点介绍了PNIs的临床负担以及解决神经间隙的最新治疗方法。接下来,讨论了指导研究解决方案的神经超微结构的简要说明。随后对比了用于修复周围神经连续性的现有生物工程策略。此外,我们阐述了3D打印和生物制造在周围神经建模与工程中的最新进展。最后还对限制该领域发展的主要挑战及其可能的解决方案进行了批判性分析。影响声明复杂的神经损伤,包括临界尺寸间隙(>3厘米组织缺损)、涉及神经分叉的间隙以及与缺血环境相关的间隙,难以处理。目前缺乏一种仿生的、个性化的周围神经组织替代物来解决这些损伤。周围神经修复市场目前是一个价值数十亿美元的产业,预计还会扩大。鉴于这种疾病带来的临床和经济困境,设计新颖有效的神经替代物至关重要。在这篇综述文章中,我们讨论了三维打印技术的进展,包括生物制造和神经计算机辅助设计建模,以实现患者特异性和仿生的神经修复解决方案。